Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13403904 | 0.83 | CYP1A2 (0.58) | CYP1A2CYP2C9CYP2D6CYP2C19SMN1; SMN2 | |
| SCHEMBL24568676 | 0.82 | CYP1A2 (0.62) | CYP1A2CYP2C9CYP2D6CYP2C19SMN1; SMN2 | |
| SCHEMBL21325281 | 0.82 | CYP1A2 (0.62) | CYP1A2CYP2C9CYP2D6CYP2C19SMN1; SMN2 | |
| SCHEMBL23464918 | 0.81 | — | — | |
| SCHEMBL3009879 | 0.79 | SMN1; SMN2 (0.67) | CYP1A2CYP2C9CYP2D6CYP2C19SMN1; SMN2 | |
| SCHEMBL23331595 | 0.79 | SMN1; SMN2 (0.67) | CYP1A2CYP2C9CYP2D6CYP2C19SMN1; SMN2 | |
| SCHEMBL27425666 | 0.79 | CYP1A2 (0.54) | CYP1A2CYP2C9CYP2D6CYP2C19SMN1; SMN2 | |
| SCHEMBL15592832 | 0.78 | CYP1A2 (0.57) | CYP1A2CYP2C9CYP2D6CYP2C19SMN1; SMN2 | |
| SCHEMBL28885160 | 0.78 | CYP1A2 (0.57) | CYP1A2CYP2C9CYP2D6CYP2C19SMN1; SMN2 | |
| SCHEMBL3120355 | 0.77 | SMN1; SMN2 (0.64) | CYP1A2CYP2C9CYP2D6CYP2C19SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024133721-A1 | COMBINATIONS OF CTPS1 INHIBITOR WITH IAP INHIBITOR FOR USE IN THE TREATMENT OF CANCER | STEP PHARMA S.A.S. (FR) | 2024-06-27 | — | — | WO | disclosed |
| WO-2023166080-A1 | COMBINATION TREATMENTS COMPRISING A CTPS1 INHIBITOR AND A WEE1 INHIBITOR | STEP PHARMA S.A.S. (FR) | 2023-09-07 | — | — | WO | disclosed |